Generic Drug Review June 2012

Combination Therapy in Hypertension Management

The use of combination therapy by a single-dosage form allows patients to achieve their blood pressure goal quickly, improves adverse drug reactions, and is supported by prospective data.

Drug Patent Expirations and the “Patent Cliff”

Beginning in 2010, the pharmaceutical industry faced one of the biggest waves of drug patent expirations in history, a phenomenon referred to as the “patent cliff.”

Generic Injectable Supply Shortages

Addressing supply interruptions requires collaboration and guidelines to manage patient care, especially in the midst of highly specialized medication regimens.

Legislative and Regulatory Issues Affecting Generic Drug Reimbursement

The increased use of generic medications is an important strategy in managing overall pharmaceutical spending, especially by Medicaid and other government-run health programs.

Pharmacy Law: Brand-Name and Generic Drugs Not Equivalent in Malpractice Claims

Based on last year's Supreme Court ruling, generic manufacturers cannot be held liable for inadequate warning labels.

Trends in Generic Drugs

More than two-thirds of all prescriptions dispensed in the U.S. are for generic drugs.

Understanding Drug Pricing

Drug costs are influenced by a variety of factors, and the complexity can be overwhelming for health care professionals and patients alike.

Continuing Education

$7.95 Per CE Exam or $69 for 12 Lessons